Table 1 CD72 expression associated with clinicopathological characteristics (baseline data sheet)
Characteristics | Low expression of CD72 | High expression of CD72 | P value |
|---|---|---|---|
n | 270 | 271 | Â |
Pathologic T stage, n (%) |  |  | < 0.001 |
 T1 | 164 (30.3%) | 115 (21.3%) |  |
 T2 | 30 (5.5%) | 41 (7.6%) |  |
 T3 | 76 (14%) | 104 (19.2%) |  |
 T4 | 0 (0%) | 11 (2%) |  |
Pathologic N stage, n (%) | Â | Â | 0.091 |
 N0 | 113 (43.8%) | 129 (50%) |  |
 N1 | 4 (1.6%) | 12 (4.7%) |  |
Pathologic M stage, n (%) |  |  | < 0.001 |
 M0 | 227 (44.7%) | 202 (39.8%) |  |
 M1 | 25 (4.9%) | 54 (10.6%) |  |
Pathologic stage, n (%) |  |  | < 0.001 |
 Stage I | 161 (29.9%) | 112 (20.8%) |  |
 Stage II | 26 (4.8%) | 33 (6.1%) |  |
 Stage III | 57 (10.6%) | 66 (12.3%) |  |
 Stage IV | 25 (4.6%) | 58 (10.8%) |  |
Primary therapy outcome, n (%) | Â | Â | 0.163 |
 PD | 4 (2.7%) | 7 (4.8%) |  |
 SD | 5 (3.4%) | 1 (0.7%) |  |
 PR | 2 (1.4%) | 0 (0%) |  |
 CR | 71 (48.3%) | 57 (38.8%) |  |
Gender, n (%) | Â | Â | 0.054 |
 Female | 104 (19.2%) | 83 (15.3%) |  |
 Male | 166 (30.7%) | 188 (34.8%) |  |
Race, n (%) | Â | Â | 0.024 |
 Asian | 1 (0.2%) | 7 (1.3%) |  |
 Black or African American | 35 (6.6%) | 22 (4.1%) |  |
 White | 233 (43.6%) | 236 (44.2%) |  |
Age, n (%) | Â | Â | 0.764 |
 <  = 60 | 136 (25.1%) | 133 (24.6%) |  |
 > 60 | 134 (24.8%) | 138 (25.5%) |  |
Histologic grade, n (%) |  |  | < 0.001 |
 G1 | 11 (2.1%) | 3 (0.6%) |  |
 G2 | 136 (25.5%) | 100 (18.8%) |  |
 G3 | 92 (17.3%) | 115 (21.6%) |  |
 G4 | 24 (4.5%) | 52 (9.8%) |  |
Serum calcium, n (%) | Â | Â | 0.366 |
 Low | 114 (31.1%) | 90 (24.5%) |  |
 Normal | 74 (20.2%) | 79 (21.5%) |  |
 Elevated | 5 (1.4%) | 5 (1.4%) |  |
Hemoglobin, n (%) | Â | Â | 0.093 |
 Low | 124 (26.9%) | 140 (30.4%) |  |
 Normal | 106 (23%) | 86 (18.7%) |  |
 Elevated | 4 (0.9%) | 1 (0.2%) |  |
Laterality, n (%) |  |  | < 0.001 |
 Left | 105 (19.4%) | 148 (27.4%) |  |
 Right | 164 (30.4%) | 123 (22.8%) |  |